Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

August 08, 2024 16:05 ET | Source: Cardiff Oncology, Inc.

Cardiff Oncology Reports Second Quarter 2024 Results and Provides Business Update

- Initial readout from first-line RAS-mut. mCRC randomized CRDF-004 trial expected in 2H 2024 - - Published preclinical data underscores the ability of onvansertib to overcome resistance to PARP...
May 29, 2024 16:05 ET | Source: Cardiff Oncology, Inc.

Cardiff Oncology to Present at the Jefferies Healthcare Conference

SAN DIEGO, May 29, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
February 26, 2024 08:00 ET | Source: Cardiff Oncology, Inc.

Cardiff Oncology to Present at the Cowen 44th Annual Health Care Conference

SAN DIEGO, Feb. 26, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...
February 22, 2024 08:00 ET | Source: Cardiff Oncology, Inc.

Cardiff Oncology to Report Fourth Quarter and Full Year 2023 Results and Provide Business Update

- Management will hold a conference call on Thursday, February 29 at 4:30 p.m. ET/1:30 p.m. PT - SAN DIEGO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage...